Techfields Inc: Clinical Trials

2 trials sponsored by Techfields Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Suspended 1, Terminated 1

Follow Techfields Inc: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults
TF0023 - COVID-19 Pneumonia
Phase 2TerminatedTechfields Inc192022-05-102024-01-08
A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
TF0023 - Ischemic Stroke
Phase 2SuspendedTechfields Inc2252017-03-012024-01-05

Conditions studied

COVID-19 (1)  ·  Ischemic Stroke (1)  ·  Pneumonia (1)

Interventions

Bulk Drugs (1)

Countries

United States (2)  ·  South Africa (1)

Top investigators

Chongxi Yu, Ph.D (2)